Analysis Version
v1
History
Back
mechanistic
Analysis v1
Strong Support

Blocking a protein called PCSK9 with certain drugs helps your body remove bad cholesterol from your blood more effectively.

63
Pro
0
Against

Evidence from Studies

Supporting (4)

63

Community contributions welcome

63

Effects of AMG 145 on low-density lipoprotein cholesterol levels: results from 2 randomized, double-blind, placebo-controlled, ascending-dose phase 1 studies in healthy volunteers and hypercholesterolemic subjects on statins.

Randomized Controlled Trial
Human
2012 Nov 6

The study tested a drug called evolocumab, which blocks a protein (PCSK9) that removes LDL receptors. By blocking it, the body can clear bad cholesterol better, just like the claim says.

1

PCSK9 Inhibition: Insights From Clinical Trials and Future Prospects

Narrative Review
In Vitro
2020

The study shows that drugs like evolocumab block a protein (PCSK9) that normally destroys LDL receptors in the liver. With more receptors available, the body can remove bad cholesterol from the blood more effectively, which matches the claim.

1

The role of PCSK9 in heart failure and other cardiovascular diseases—mechanisms of action beyond its effect on LDL cholesterol

Narrative Review
2024 Sep

The study shows that drugs like evolocumab block a protein called PCSK9, which helps the body remove bad cholesterol from the blood by saving the receptors that clear it.

1

Therapeutic PCSK9 targeting: Inside versus outside the hepatocyte?

Narrative Review
2025 Apr

The study looks at drugs like evolocumab that block a protein called PCSK9, which helps the body remove bad cholesterol from the blood. This matches the claim exactly.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Similar Assertions

These special lab-made antibodies grab onto a protein in your blood that messes with cholesterol cleanup, so your body can get rid of bad cholesterol better and lower your chances of heart problems.

1
0
88%

A type of medicine (like evolocumab or alirocumab) blocks a protein in your body called PCSK9, which helps your liver remove bad cholesterol from your blood—cutting it by about half.

1
0
87%

A protein called PCSK9 causes the liver to break down fewer 'bad' cholesterol carriers, which means more of it stays in your blood.

1
0
80%

Taking a cholesterol drug called evolocumab to get really low LDL levels doesn’t seem to cause serious side effects like memory problems, diabetes, cataracts, or brain bleeds over 3 years, according to a major study.

1
0
77%

Taking a drug called evolocumab can lower the chance of having a first major heart problem by 25% in people at high risk who’ve never had a heart attack or stroke before.

95
55
76%

Related Content